MARATTO

article · Engineering Science & Technology Journal

Comprehensive review of metal complexes and nanocomposites: Synthesis, characterization, and multifaceted biological applications

202413 citationsOpen accessFederal University of Agriculture

Abstract

This review paper provides an extensive analysis of the synthesis, characterization, and multifaceted biological applications of metal complexes and nanocomposites derived from a diverse array of biopolymeric ligands. These ligands, including chitosan, 2-hydroxybenzaldehyde, and 4-aminopyridine imine, among others, have shown remarkable potential due to their biocompatibility, biodegradability, and functional versatility. The review delves into various synthetic strategies, including conventional and green synthesis approaches, and highlights advanced characterization techniques such as spectroscopy, microscopy, thermal analysis, and X-ray diffraction. Emphasizing the broad spectrum of biological activities exhibited by these compounds, the review covers antimicrobial, anticancer, antioxidant, enzyme inhibition, and drug delivery applications. By synthesizing current research and identifying key challenges and future directions, this review aims to provide valuable insights for researchers in medicinal chemistry, materials science, biotechnology, and related fields. Keywords: Metal Complexes, Nanocomposites, Synthesis, Characterization, Biological Application.

Research topics

  • Synthesis and biological activity
  • Multicomponent Synthesis of Heterocycles

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.51594/estj.v5i6.1215

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.